<DOC>
	<DOCNO>NCT02271360</DOCNO>
	<brief_summary>The purpose study compare effect oral Calcium Dobesilate oral Cabergoline prevention ovarian hyperstimulation syndrome ( OHSS ) high-risk woman underwent intracytoplasmic sperm injection ( ICSI ) .</brief_summary>
	<brief_title>Calcium Dobesilate Versus Cabergoline Prevention Ovarian Hyperstimulation Syndrome</brief_title>
	<detailed_description>Two hundred twenty woman risk ovarian hyperstimulation syndrome ICSI cycle randomly schedule two equal group . In group A , ( Calcium Dobesilate group ) , 1 cap / 8 h Doxium ( 500mg ) give day HCG injection 21 day ; group B ( Cabergoline group ) , 1 tab/day Cabergoline ( 0.5 mg ) give day HCG injection 8 day .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Cabergoline</mesh_term>
	<mesh_term>Calcium Dobesilate</mesh_term>
	<criteria>Patients enrol study infertile woman undergo ICSI one follow criterion : previous episode OHSS , polycystic ovary ( i.e. , &gt; 24 antral follicle present baseline ultrasound examination ) , high AMH ( &gt; 3.0 ng/mL ) , large number small follicle ( 8 12 mm ) see ultrasound ovarian stimulation , high s.E2 hCG trigger ( E2 &gt; 3000 pg/ml rapidly rise s.E2 ) , presence &gt; 20 follicle ultrasound day retrieval large number oocyte retrieve ( &gt; 20 ) .</criteria>
	<gender>Female</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>infertility ICSI OHSS Calcium Dobesilate Cabergoline</keyword>
</DOC>